Inspire Medical Systems EU’s Post

CPAP Humidifiers Usage, Common Problems, and Solutions For individuals using Continuous Positive Airway Pressure (CPAP) for sleep apnea therapy, a humidifier can significantly enhance comfort and compliance. CPAP humidifiers add moisture to the air delivered by the machine, preventing dryness and irritation in the nasal passages and throat. For More-> https://lnkd.in/d5Z8BZ5v

Relief of Obstructive Sleep Apnea Shown Superior With Implantable Devices There is a growing body of scientific literature that supports the efficacy of implantable Hypoglossal Nerve Stimulators (HNS) for the treatment of Obstructive Sleep Apnea (OSA). Overall, the scientific literature suggests that HNS is as effective for treatment for OSA as Continuous Positive Airway Pressure (CPAP), but with a higher patient acceptance rate. HNS is particularly effective for people with severe OSA who have not responded to other treatments, such as CPAP. If you or someone you know is suffering from OSA, we highly recommend you seek out a doctor familiar with implantable Hypoglossal Nerve Stimulators to see if this option is right for you. Please click on the link to read the blog post - https://lnkd.in/d-wtS5t8 Please Like and Comment if you find this post useful. #SleepApnea #ObstructiveSleepApnea #OSADevice #CPAP #HNS

💤 26 studies backed by ResMed at ATS 2024 highlighted the rising prevalence of obstructive sleep apnea (OSA) and the critical role of CPAP therapy. Key lectures included how effective CPAP therapy reduces hospitalization and all-cause mortality rates. Which talks did you attend at ATS? Full article below: https://lnkd.in/eGQc5yAf #consult #medexec #resmed #sleepapnea #ats2024

Add Sleep Apnea to the GLP-1 expanding list for medical conditions with efficacy Tirzepatide (GLP-1) clicks for protection vs sleep apnea in 2 randomized placebo-controlled trials: less symptoms, hypoxia, systolic BP, and reduction of inflammation by hs-CRP (w/ or w/o CPAP) https://lnkd.in/gHzAGmYC

TUFTS in GREECE 2025!!! TUSDM CE is proud to host our First Global TMD and Sleep Symposium - Sleep Apnea: New Diagnostic and Therapeutic Paradigms on March 14-15, 2025 in Athens, Greece. Our two-day symposium is designed to outline the need for non-CPAP therapies in treating Obstructive Sleep Apnea (OSA) and outline why Oral Appliance Therapy (OAT) is the optimal choice, review the implications for OSA for cardiovascular disease, examine and explore the importance of hypoxic-based surrogates in evaluating the risk of long-term adverse health outcomes in OSA, assess the efficacy of OAT and the advances associated with precision oral appliances, review the evidence for treating severe OSA with precision oral appliances, evaluate the safety and side effects of oral appliances and treating OSA, examine the adverse effects of CPAP on the cardiovascular system, and health outcomes and explore the relative advantages of CPAP versus OAT in treating moderate and severe OSA. REGISTER NOW!!! https://rb.gy/tbkua2 #tusdmce #implantsymposium #implantdentistry #continuingeducation

Relief of Obstructive Sleep Apnea Shown Superior With Implantable Devices There is a growing body of scientific literature that supports the efficacy of implantable Hypoglossal Nerve Stimulators (HNS) for the treatment of Obstructive Sleep Apnea (OSA). Overall, the scientific literature suggests that HNS is as effective for treatment for OSA as Continuous Positive Airway Pressure (CPAP), but with a higher patient acceptance rate. HNS is particularly effective for people with severe OSA who have not responded to other treatments, such as CPAP. If you or someone you know is suffering from OSA, we highly recommend you seek out a doctor familiar with implantable Hypoglossal Nerve Stimulators to see if this option is right for you. Please click on the link to read the blog post - https://lnkd.in/drRCBaAZ Please Like and Comment if you find this post useful. #SleepApnea #OSATreatment #HypoglossalNerveStimulator #ObstructiveSleepApnea #CPAP #OSA

Remarkable and promising potential of GLP-1 to reset a growing list of chronic conditions with massive economic and societal scale impact.

Tired of dealing with CPAP machines? A drug shows promise for sleep apnea 💊Sulthiame (Ospolot), an epilepsy drug marketed since the ’60s, has demonstrated efficacy in reducing obstructive sleep apnea. Sulthiame significantly reduced breathing interruptions and improved oxygen levels in nearly 300 sleep apnea patients. This could be a turning point for individuals who find CPAP therapy uncomfortable or ineffective. ▶️ It is estimated that approximately 44% of Europeans, about 175M people have obstructive sleep apnea (OSA). ▶️ A CPAP (continuous positive airway pressure) machine helps treat sleep apnea. ▶️Further research is needed to explore the long-term benefits, potential side effects, and the specific patient subgroups that may benefit most from this treatment. #obstructivesleep #apnea #OSA #epilepsy #drugtherapy  #drugrepurposing #lifesciences #healthcare #SahlgrenskaUniversityHospital #UniversityofGothenburg 🇸🇪 If you like this post, please share ♻️ Follow me for more 💡 — Disclaimer:  This post represents my personal view and does not reflect those of any past, present, or future employer.

NEW COURSE COMING in Q1 of 2025: "From Complaints to Compliance" Sleep medicine professionals sharing their expertise, best practices and the latest research around the role of CPAP masks and treating obstructive sleep apnea (OSA). This webinar discussion covers: ☑️ Non-adherent patient groups ☑️ Common pitfalls during treatment setup ☑️ The importance of mask selection ☑️ Case studies from the clinic ☑️ Gaps in patient follow-up SEE TRAILER: https://lnkd.in/drmaExD5

[New Research 💤] Faster, Accurate Diagnosis for Obstructive Sleep Apnoea with Mandibular Movement Monitor. 🔍 Study Overview A new multicentric randomized controlled study has put the spotlight on the efficiency of the Sunrise mandibular movement monitor in diagnosing obstructive sleep apnoea (OSA). Conducted with 40 adults with high pre-test probability for OSA, the study compared Sunrise to respiratory polygraphy, the UK's most common OSA detection method. 🌟 Key Results - Efficiency: Sunrise reduced the time to treatment decision by 30% compared to respiratory polygraphy. - Time-saving: It saved about 30 minutes of staff time per patient. - Accuracy: Sunrise showed good agreement with respiratory polygraphy in clinical treatment decisions. 🏡 Impact This breakthrough makes diagnosing OSA more accessible, accurate, and patient-friendly. It's a promising step toward broader adoption and better patient compliance. 👉 For more details on this study, read the full article in Clinical Medicine Journal https://lnkd.in/e6pGuiYK. Kudos to the authors!